Avanos MedicalAVNS +0.20%62 Gross Margin % is 51.70% as of Mar. 2026, which is 6% below its 10-year median of 55.27. GuruFocus rates AVNS with a GF Score™ of 62/100 and a GF Value™ of $19.42 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Avanos Medical ranks worse than 53.04% on this metric.
The historical rank and industry rank for Avanos Medical's Gross Margin % or its related term are showing as below:
AVNS'
s Gross Margin % Range Over the Past 10 Years
Min: 50.05 Med: 55.27 Max: 59.93
Current: 50.05
During the past 13 years, the highestGross Margin % of Avanos Medical was 59.93%. The lowest was 50.05%. And the median was 55.27%.
AVNS's Gross Margin % is ranked worse than 53.04% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs AVNS: 50.05
Avanos Medical had a gross margin of 51.70% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Avanos Medical was 0.20% per year.
Avanos Medical (NYSE:AVNS) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Avanos Medical had a gross margin of 51.70% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Avanos Medical Gross Margin % Related Terms
Avanos Medical Gross Margin % Historical Data
* Premium members only.
The historical data trend for Avanos Medical's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AVNS vs IRMD, TNDM, ATEC: Gross Margin % Comparison
For the Medical Devices subindustry, Avanos Medical's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avanos Medical Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Avanos Medical's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Avanos Medical's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Avanos Medical (AVNS) has a Gross Margin % of 51.70% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Avanos Medical and its competitors. This is near median its historical median of 55.27. Over the past decade, Avanos Medical's Gross Margin % has ranged from 50.05 to 59.93. According to the industry distribution chart, Avanos Medical ranks #427 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 53%.
Is Avanos Medical's Gross Margin % too high?
Avanos Medical's current Gross Margin % of 51.70% is near median its 10-year median of 55.27. Over the past 10 years, this metric has ranged from a low of 50.05 to a high of 59.93. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Avanos Medical's value of 51.70% is 0.7% below this industry median. Based on the distribution chart, Avanos Medical ranks #427 out of 805 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Avanos Medical has a GF Score™ of 62/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Avanos Medical's Gross Margin % compare to IRMD and TNDM?
According to the Medical Devices & Instruments industry distribution chart, Avanos Medical ranks #427 out of 805 companies for Gross Margin %. This places Avanos Medical in the lower half of its industry. The industry median Gross Margin % is 52.07. Avanos Medical's value of 51.70% is 0.7% below this benchmark. Historically, Avanos Medical's own Gross Margin % has ranged from 50.05 to 59.93 over the past decade. While the company's 10-year median is 55.27 vs. the industry median of 52.07, Avanos Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avanos Medical's current Gross Margin % of 51.70% is 0.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Avanos Medical and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avanos Medical's current Gross Margin % is 51.70%, which is near median its own 10-year median of 55.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avanos Medical stock overvalued right now?
Based on GuruFocus' analysis, Avanos Medical (AVNS) is currently considered Modestly Overvalued. The stock's GF Value™ is $19.42, compared to a current price of $24.95 — trading 28.5% above its estimated fair value. The current Gross Margin % is 51.70%, which is near median its 10-year median of 55.27 and 0.7% below the Medical Devices & Instruments industry median of 52.07. Avanos Medical's overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Avanos Medical (AVNS), the current Gross Margin % is 51.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Avanos Medical (AVNS) Overvalued in 2026?
Based on GuruFocus' analysis, Avanos Medical stock appears to be overvalued.
The current stock price of $24.95 is trading 28.5% above its estimated GF Value™ of $19.42.
GuruFocus considers Avanos Medical to be Modestly Overvalued.
Key valuation signals for AVNS:
Gross Margin %: 51.70% (near median its 10-year median of 55.27)
GF Value™: $19.42 vs. price of $24.95 (28.5% above fair value)
Industry Position: 0.7% below the Medical Devices & Instruments median (#427 of 805)
No single metric tells the full story. See the AVNS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.
62GF Score
Get the complete analysis for AVNS
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AVNS has been successfully added to your 
